SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-121359
Filing Date
2017-04-12
Accepted
2017-04-12 16:06:33
Documents
3
Period of Report
2017-05-23
Effectiveness Date
2017-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d334678ddef14a.htm DEF 14A 407845
2 GRAPHIC g334678pcpg01a.jpg GRAPHIC 6008
3 GRAPHIC g334678pcpg01b.jpg GRAPHIC 10619
  Complete submission text file 0001193125-17-121359.txt   432136
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36913 | Film No.: 17758062
SIC: 2834 Pharmaceutical Preparations